カンナビノイドの世界市場レポート 2025年

カンナビノイドの市場規模は、今後数年で飛躍的な成長が見込まれます。2029年には年間平均成長率（CAGR）21.1％で1,019億米ドルに成長します。予測期間の成長は、より広範な合法化と非犯罪化、研究の進歩、多様な製品の提供、国際市場の拡大、公衆衛生意識向上への取り組みなどに起因すると考えられます。予測期間中の主な動向としては、受容の拡大と脱染色化、製品提供の多様化、送達方法の革新、品質と安全性の基準、社会的公正と包括性への取り組みなどが挙げられます。

慢性疾患の有病率の増加は、カンナビノイド市場の成長を促進すると予想されます。慢性疾患は、一般的に継続的な医療を必要とする長期にわたる疾患です。ランダム化比較試験のシステマティック・レビューでは、燻製大麻、大麻ベースの薬剤の粘膜抽出物、ナビロン、ドロナビノール、新しいTHC類似物質を含むカンナビノイドの、慢性非がん性疼痛の管理における有効性が検討されました。例えば、2023年9月、スイスに本部を置く国連機関である世界保健機関（WHO）は、世界の死亡者数の74％にあたる4,100万人が毎年、非感染性疾患（NCDs）または慢性疾患によって死亡していると報告しました。その結果、慢性疾患の有病率の増加がカンナビノイド市場の拡大に拍車をかけています。

がんの有病率の増加は、カンナビノイド市場の成長を促進すると予想されています。がんは、体の細胞の一部が制御不能に増殖し、体の他の部分に広がる状態です。カンナビノイドは、神経障害、吐き気、疼痛、嘔吐、食欲不振、体重減少などの症状を管理することで、がん患者をサポートするために使用されることが増えています。さらに、カンナビノイドはオートファジーを刺激し、アポトーシス（細胞死）につながるシグナル伝達経路に影響を与えることにより、がんの進行に影響を与えることができます。例えば、2022年1月、米国がん協会は、米国におけるがんの新規患者数は191万8,030人、がん関連死亡者数は60万9,360人と推定されると報告しました。このうち、肺がんによる死亡者は毎日約350人と予想され、がん関連死の主な原因であることに変わりはないです。その結果、がんの有病率の増加がカンナビノイド市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のカンナビノイド PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のカンナビノイド市場：成長率分析
• 世界のカンナビノイド市場の実績：規模と成長, 2019-2024
• 世界のカンナビノイド市場の予測：規模と成長, 2024-2029, 2034F
• 世界のカンナビノイド総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のカンナビノイド市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• カンナビジオール
• テトラヒドロカンナビノール
• カンナビノール
• その他の製品タイプ
• 世界のカンナビノイド市場：流通先別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンラインストア
• 世界のカンナビノイド市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医療
• レクリエーション
• 産業用ヘンプ
• 世界のカンナビノイド市場：カンナビジオール（CBD）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• フルスペクトラムCBD
• ブロードスペクトラムCBD
• CBDアイソレート
• 世界のカンナビノイド市場：テトラヒドロカンナビノール（THC）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• デルタ-9 THC
• デルタ-8 THC
• 世界のカンナビノイド市場：カンナビノール（CBN）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• CBNアイソレート
• CBNオイル
• 世界のカンナビノイド市場：その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• カンナビゲロール（CBG）
• カンナビクロメン（CBC）
• テルペンとその他の植物性カンナビノイド

第7章 地域別・国別分析

• 世界のカンナビノイド市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のカンナビノイド市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• カンナビノイド市場：競合情勢
• カンナビノイド市場：企業プロファイル
  • The Supreme Cannabis Company Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Elixinol Global Limited Overview, Products and Services, Strategy and Financial Analysis
  • GW Pharmaceuticals PLC. Overview, Products and Services, Strategy and Financial Analysis
  • Tilray Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Aurora Cannabis Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Innovative Ind Props
• Curaleaf Holdings Inc.
• Green Thumb Industries
• Verano Holdings
• Trulieve Cannabis Corp.
• Cresco Labs Inc.
• Cronos Group
• TerrAscend Corp.
• Canopy Growth Corp.
• Sundial Growers Inc.
• Decibel Cannabis Company
• Auxly Cannabis Group
• Red White & Bloom Brands
• BZAM Ltd
• Delta 9 Cannabis Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• カンナビノイド市場2029：新たな機会を提供する国
• カンナビノイド市場2029：新たな機会を提供するセグメント
• カンナビノイド市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cannabinoids are specific chemical compounds found in marijuana that exert effects on the immune and central nervous systems similar to certain drugs. These compounds are utilized to alleviate side effects or symptoms associated with chronic diseases, particularly in the context of cancer treatment.

The primary types of cannabinoid products include cannabidiol (CBD), tetrahydrocannabinol (THC), cannabinol, and other variants. Cannabidiol is employed in the treatment of conditions such as seizures, anxiety, insomnia, chronic pain, and tobacco addiction. It is a chemical component derived from the cannabis sativa plant or hemp. The distribution channels for cannabinoids encompass hospital pharmacies, retail pharmacies, and online stores. Applications for cannabinoids span medical, recreational, and industrial hemp uses.

The cannabinoids protection market research report is one of a series of new reports from The Business Research Company that provides cannabinoids market statistics, including cannabinoids industry global market size, regional shares, competitors with a cannabinoids market share, detailed cannabinoids market segments, market trends and opportunities, and any further data you may need to thrive in the cannabinoids industry. This cannabinoids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cannabinoids market size has grown exponentially in recent years. It will grow from $39.45 billion in 2024 to $47.43 billion in 2025 at a compound annual growth rate (CAGR) of 20.2%. The growth in the historic period can be attributed to medical cannabis legalization, increasing acceptance of cannabis, research and development, regulatory changes, growing awareness of cannabinoid benefits, investments in cannabis industry, consumer trends toward natural products.

The cannabinoids market size is expected to see exponential growth in the next few years. It will grow to $101.9 billion in 2029 at a compound annual growth rate (CAGR) of 21.1%. The growth in the forecast period can be attributed to wider legalization and decriminalization, research advancements, diverse product offerings, international market expansion, public health awareness initiatives. Major trends in the forecast period include increasing acceptance and destigmatization, diversification of product offerings, innovation in delivery methods, quality and safety standards, social equity and inclusivity initiatives.

The increasing prevalence of chronic diseases is expected to drive the growth of the cannabinoid market. Chronic diseases are long-lasting conditions that typically require ongoing medical care. A systematic review of randomized controlled trials examined the effectiveness of cannabinoids, including smoked marijuana, oromucosal extracts of cannabis-based medications, nabilone, dronabinol, and a new THC analogue, in managing chronic noncancer pain. For example, in September 2023, the World Health Organization (WHO), a Switzerland-based United Nations agency, reported that 41 million deaths, or 74% of global deaths, were caused by non-communicable diseases (NCDs) or chronic diseases annually. Consequently, the growing prevalence of chronic diseases is fueling the expansion of the cannabinoid market.

The rising prevalence of cancer is expected to drive the growth of the cannabinoid market. Cancer is a condition in which some of the body's cells grow uncontrollably and spread to other parts of the body. Cannabinoids are increasingly used to support cancer patients by managing symptoms such as neuropathy, nausea, pain, vomiting, appetite loss, and weight loss. Additionally, cannabinoids can influence cancer progression by stimulating autophagy and affecting signaling pathways that lead to apoptosis (cell death). For example, in January 2022, the American Cancer Society reported an estimated 1,918,030 new cancer cases and 609,360 cancer-related deaths in the United States. Among these, around 350 people are expected to die each day from lung cancer, which remains the leading cause of cancer-related deaths. As a result, the increasing prevalence of cancer is contributing to the growth of the cannabinoid market.

Major companies in the cannabinoids market are strategically focusing on introducing advanced cannabis-based cosmetic solutions to gain a competitive edge. Cannabis-based cosmetic solutions, like CBG and CBD rescue cream, are formulated with cannabis derivatives to offer skin moisturizing, anti-aging, and anti-inflammatory effects. For instance, in November 2022, British Cannabis, a UK-based producer, introduced the Synergy CBG and CBD Rescue Cream, the first cannabis cosmetic in the UK to undergo clinical trials. This innovative product reflects a commitment to creating comprehensive skincare solutions in the cannabinoid market.

Major companies in the cannabinoids market are focusing on developing innovative solutions like fast-acting cannabinoids to enhance the efficacy and speed of therapeutic effects. Fast-acting cannabinoids refer to formulations that deliver quicker relief compared to traditional methods. For example, in August 2024, Rare Cannabinoid, a US-based health and wellness company, launched Fast-Acting Nano THC + CBC Mood Mints. These mints provide rapid effects, allowing users to feel the benefits of delta-9-THC and cannabichromene (CBC) within 15 to 30 minutes, compared to the usual 30 to 90 minutes for traditional edibles. Using advanced nanotechnology, the mints offer customizable dosing options, ideal for microdosing and personalized use.

In January 2022, Dermapharm Holding SE, a Germany-based pharmaceutical company, acquired C3 Group for an undisclosed amount. The acquisition aimed to strengthen Dermapharm Holding's position in the growing cannabis market by enhancing its cannabinoid production capabilities, expanding its distribution channels across Europe, and deepening its expertise in therapeutic solutions for serious medical conditions. This move comes as regulatory changes increasingly favor the acceptance of medical cannabis. C3 Group, a Poland-based company, specializes in cannabinoid compounds, contributing to Dermapharm's strategic push into this emerging sector.

Major companies operating in the cannabinoids market are The Supreme Cannabis Company Inc., Elixinol Global Limited, GW Pharmaceuticals PLC., Tilray Inc., Aurora Cannabis Inc., Innovative Ind Props, Curaleaf Holdings Inc., Green Thumb Industries, Verano Holdings, Trulieve Cannabis Corp., Cresco Labs Inc., Cronos Group, TerrAscend Corp., Canopy Growth Corp., Sundial Growers Inc., Decibel Cannabis Company, Auxly Cannabis Group, Red White & Bloom Brands, BZAM Ltd, Delta 9 Cannabis Inc., Mylan N.V., Westleaf Cannabis Inc., GrowGeneration, The Scotts Miracle-Gro Company, Jazz Pharmaceuticals PLC, Aphria Inc., Organigram Inc., Alkem labs, MediPharm Labs Corp., The Valens GroWorks Inc.

North America was the largest region in the cannabinoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabinoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cannabinoids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cannabinoids market consists of sales of cannabidiolic acid, flowers/buds and concentrates. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cannabinoids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cannabinoids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cannabinoids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cannabinoids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Cannabidiol; Tetrahydrocannabinol; Cannabinol; Other Product Types
• 2) By Distribution: Hospital Pharmacies; Retail Pharmacies; Online Stores
• 3) By Application: Medical; Recreational; Industrial Hemp
• Subsegments:
• 1) By Cannabidiol (CBD): Full-Spectrum CBD; Broad-Spectrum CBD; CBD Isolate
• 2) By Tetrahydrocannabinol (THC): Delta-9 THC; Delta-8 THC
• 3) By Cannabinol (CBN): CBN Isolate; CBN Oil
• 4) By Other Product Types: Cannabigerol (CBG); Cannabichromene (CBC); Terpenes And Other Phytocannabinoids
• Companies Mentioned: The Supreme Cannabis Company Inc.; Elixinol Global Limited; GW Pharmaceuticals PLC.; Tilray Inc.; Aurora Cannabis Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cannabinoids Market Characteristics

3. Cannabinoids Market Trends And Strategies

4. Cannabinoids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Cannabinoids Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cannabinoids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cannabinoids Market Growth Rate Analysis
• 5.4. Global Cannabinoids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cannabinoids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cannabinoids Total Addressable Market (TAM)

6. Cannabinoids Market Segmentation

• 6.1. Global Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cannabidiol
• Tetrahydrocannabinol
• Cannabinol
• Other Product Types
• 6.2. Global Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Stores
• 6.3. Global Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical
• Recreational
• Industrial Hemp
• 6.4. Global Cannabinoids Market, Sub-Segmentation Of Cannabidiol (CBD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Full-Spectrum CBD
• Broad-Spectrum CBD
• CBD Isolate
• 6.5. Global Cannabinoids Market, Sub-Segmentation Of Tetrahydrocannabinol (THC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Delta-9 THC
• Delta-8 THC
• 6.6. Global Cannabinoids Market, Sub-Segmentation Of Cannabinol (CBN), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CBN Isolate
• CBN Oil
• 6.7. Global Cannabinoids Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cannabigerol (CBG)
• Cannabichromene (CBC)
• Terpenes And Other Phytocannabinoids

7. Cannabinoids Market Regional And Country Analysis

• 7.1. Global Cannabinoids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cannabinoids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cannabinoids Market

• 8.1. Asia-Pacific Cannabinoids Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cannabinoids Market

• 9.1. China Cannabinoids Market Overview
• 9.2. China Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cannabinoids Market

• 10.1. India Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cannabinoids Market

• 11.1. Japan Cannabinoids Market Overview
• 11.2. Japan Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cannabinoids Market

• 12.1. Australia Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cannabinoids Market

• 13.1. Indonesia Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cannabinoids Market

• 14.1. South Korea Cannabinoids Market Overview
• 14.2. South Korea Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cannabinoids Market

• 15.1. Western Europe Cannabinoids Market Overview
• 15.2. Western Europe Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cannabinoids Market

• 16.1. UK Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cannabinoids Market

• 17.1. Germany Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cannabinoids Market

• 18.1. France Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cannabinoids Market

• 19.1. Italy Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cannabinoids Market

• 20.1. Spain Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cannabinoids Market

• 21.1. Eastern Europe Cannabinoids Market Overview
• 21.2. Eastern Europe Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cannabinoids Market

• 22.1. Russia Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cannabinoids Market

• 23.1. North America Cannabinoids Market Overview
• 23.2. North America Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cannabinoids Market

• 24.1. USA Cannabinoids Market Overview
• 24.2. USA Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cannabinoids Market

• 25.1. Canada Cannabinoids Market Overview
• 25.2. Canada Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cannabinoids Market

• 26.1. South America Cannabinoids Market Overview
• 26.2. South America Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cannabinoids Market

• 27.1. Brazil Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cannabinoids Market

• 28.1. Middle East Cannabinoids Market Overview
• 28.2. Middle East Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cannabinoids Market

• 29.1. Africa Cannabinoids Market Overview
• 29.2. Africa Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cannabinoids Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cannabinoids Market Competitive Landscape And Company Profiles

• 30.1. Cannabinoids Market Competitive Landscape
• 30.2. Cannabinoids Market Company Profiles
  • 30.2.1. The Supreme Cannabis Company Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Elixinol Global Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GW Pharmaceuticals PLC. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Tilray Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Aurora Cannabis Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cannabinoids Market Other Major And Innovative Companies

• 31.1. Innovative Ind Props
• 31.2. Curaleaf Holdings Inc.
• 31.3. Green Thumb Industries
• 31.4. Verano Holdings
• 31.5. Trulieve Cannabis Corp.
• 31.6. Cresco Labs Inc.
• 31.7. Cronos Group
• 31.8. TerrAscend Corp.
• 31.9. Canopy Growth Corp.
• 31.10. Sundial Growers Inc.
• 31.11. Decibel Cannabis Company
• 31.12. Auxly Cannabis Group
• 31.13. Red White & Bloom Brands
• 31.14. BZAM Ltd
• 31.15. Delta 9 Cannabis Inc.

32. Global Cannabinoids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cannabinoids Market

34. Recent Developments In The Cannabinoids Market

35. Cannabinoids Market High Potential Countries, Segments and Strategies

• 35.1 Cannabinoids Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cannabinoids Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cannabinoids Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer